Chemoinformaics analysis of (8S)-15-Acetyloxylabd-13-en-8-ol
Molecular Weight | 350.543 | nRot | 5 |
Heavy Atom Molecular Weight | 312.239 | nRig | 13 |
Exact Molecular Weight | 350.282 | nRing | 2 |
Solubility: LogS | -4.959 | nHRing | 0 |
Solubility: LogP | 5.76 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
Atoms Count | 63 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 2 |
No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 22 | No. of Saturated Rings | 2 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 64.4841 |
nHD | 1 | BPOL | 40.7259 |
QED | 0.543 |
Synth | 4.058 |
Natural Product Likeliness | 2.911 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.934 |
Pgp-sub | 0 |
HIA | 0.004 |
CACO-2 | -4.614 |
MDCK | 0.0000152 |
BBB | 0.533 |
PPB | 0.953195 |
VDSS | 1.107 |
FU | 0.0391112 |
CYP1A2-inh | 0.063 |
CYP1A2-sub | 0.15 |
CYP2c19-inh | 0.151 |
CYP2c19-sub | 0.894 |
CYP2c9-inh | 0.263 |
CYP2c9-sub | 0.57 |
CYP2d6-inh | 0.024 |
CYP2d6-sub | 0.253 |
CYP3a4-inh | 0.258 |
CYP3a4-sub | 0.229 |
CL | 8.434 |
T12 | 0.1 |
hERG | 0.01 |
Ames | 0.007 |
ROA | 0.016 |
SkinSen | 0.395 |
Carcinogencity | 0.073 |
EI | 0.351 |
Respiratory | 0.837 |
NR-Aromatase | 0.097 |
Antiviral | Yes |
Prediction | 0.630481 |